Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA in moderate to severe traumatic brain injury
NCT01990768Phase 2Completed
- Sponsor
- University of Washington
- Start
- May 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tranexamic acid in traumatic brain injury (TBI), sponsored by University of Washington. Started May 2015; status: completed.
02
Drugs
tranexamic acid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01990768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01990768.